Spyre Therapeutics Insider Heidy King-Jones Sells $2.63M of Stock
Heidy King-Jones sold 28,933 shares of Spyre Therapeutics, Inc. at $89.24 to $93.46 a share (average $91.03) in 5 transactions, worth $2.63M in total on Oct 1, 2026. Shares held after the trade: 2,845 (-47.8%).
Spyre Therapeutics CEO Cameron Turtle Sells $1.37M of Stock
Cameron Turtle, CEO, sold 14,900 shares of Spyre Therapeutics, Inc. at $89.14 to $93.37 a share (average $91.99) in 5 transactions, worth $1.37M in total on Oct 1, 2026. Shares held after the trade: 537,640 (-0.9%).
Spyre Therapeutics CFO Scott L. Burrows Sells $2.26M of Stock
Scott L. Burrows, CFO, sold 25,000 shares of Spyre Therapeutics, Inc. at $89.07 to $93.57 a share (average $90.47) in 6 transactions, worth $2.26M in total between Sep 30, 2026 and Oct 1, 2026. Shares held after the trade: 79,762 (-0.3%).